-
Invivotek presents the innovative human platform for targeted delivery of bispecific interleukins to tumors at AACR 2022
PosterApr
132022 -
Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3)
Press ReleaseOct
72021 -
Genesis Drug Discovery & Development Appoints Anthony Rohr as Chief Operating Officer
Press ReleaseSep
162021 -
Genesis Drug Discovery & Development Appoints Laura Sailor Veteran CRO Business Development Leader as Director of Business Development
Press ReleaseSep
162021 -
Invivotek presents the in vivo characterization of a novel STING agonist in a non-muscle invasive bladder cancer model at AACR 2021
PosterApr
132021 -
Genesis Drug Discovery and Development acquires Integrated Analytical Solutions to add "off the shelf" PK profiling capabilities to its portfolio.
Press ReleaseMar
42021 -
Genesis Drug Discovery and Development expands its presence in the clinical space by acquiring STATKING Clinical Services
Press ReleaseJan
62021 -
Genesis Biotechnology Group announces second year of CRO relationship with Yale University
Press ReleaseDec
92020 -
Genesis Biotechnology Group acquires Comparative Biosciences, Inc. (CBI) to add GLP Toxicology and Safety Pharmacology to its portfolio of Preclinical Services
Press ReleaseAug
52020 -
Genesis Drug Discovery & Development (GD3) Announces Appointment of Anthony Rohr, as Chief Executive Officer of PharmOptima.
Press ReleaseAug
42020 -
Genesis Biotechnology Group acquires NEDP to grow the Preclinical Chemistry services portfolio of Genesis Drug Discovery & Development
Press ReleaseNov
192019 -
Genesis Drug Discovery & Development Expands Preclinical Contract Research Portfolio by Acquiring NexusPharma.
Press ReleaseJun
182019 -
Genesis Drug Discovery & Development Announces Operating Agreement with Ophthy-DS, Inc.
Press ReleaseFeb
272019 -
Genesis Biotechnology Group announces partnership with Yale University
Press ReleaseOct
302018 -
Genesis Drug Discovery & Development Appoints Olesia Buiakova, M.D., Ph.D., as Chief Scientific Officer
Press ReleaseJul
192018 -
Experimental Autoimmune Encephalomyelitis Model
Press ReleaseApr
272018 -
Invivotek Maintains Full AAALAC Accreditation for Excellence in Animal Care and Use
Press ReleaseSep
142017 -
Invivotek Completes Solar Farm and Facility Expansion
Press ReleaseMar
272017 -
Genesis Biotechnology Group Expands Preclinical Contract Research Portfolio by Acquiring PharmOptima
Press ReleaseMar
12017 -
Invivotek Awarded Full AAALAC Accreditation for Excellence in Animal Care and Use
Press ReleaseJul
142014 -
Invivotek Receives Distinguished Innovation and Achievement Award from Allentown, Inc., the Leader in Design and Installation for Quality Animal Housing
Press ReleaseNov
202013
News & Events
